Send to

Choose Destination
Kidney Int. 2015 Nov;88(5):1126-34. doi: 10.1038/ki.2015.192. Epub 2015 Jul 8.

Urinary uromodulin, kidney function, and cardiovascular disease in elderly adults.

Author information

Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA.
Department of Biostatistics, University of Washington, Seattle, Washington, USA.
Kidney Research Institute, University of Washington, Seattle, Washington, USA.
Division of Nephrology, Universty of California, San Diego, San Diego, California, USA.
Department of Nephrology and Hypertension, Cincinnati Children's Hospital, University of Cincinnati, Cincinnati, Ohio, USA.
Kidney Research Institute and Harborview Medical Center, University of Washington, Seattle, Washington, USA.
New York Academy of Medicine, New York, New York, USA.
Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA.
Division of General Internal Medicine, University of California, San Francisco, San Francisco, California, USA.
Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA.


Urinary uromodulin (uUMOD) is the most common secreted tubular protein in healthy adults. However, the relationship between uUMOD and clinical outcomes is still unclear. Here we measured uUMOD in 192 participants of the Cardiovascular Health Study with over a 30% decline in estimated glomerular filtration rate (eGFR) over 9 years, 54 with incident end-stage renal disease (ESRD), and in a random subcohort of 958 participants. The association of uUMOD with eGFR decline was evaluated using logistic regression and with incident ESRD, cardiovascular disease, heart failure, and mortality using Cox proportional regression. Mean age was 78 years and median uUMOD was 25.8 μg/ml. In a case-control study evaluating eGFR decline (192 cases and 231 controls), each 1-s.d. higher uUMOD was associated with a 23% lower odds of eGFR decline (odds ratio 0.77 (95% CI 0.62-0.96)) and a 10% lower risk of mortality (hazard ratio 0.90 (95% CI 0.83-0.98)) after adjusting for demographics, eGFR, albumin/creatinine ratio, and other risk factors. There was no risk association of uUMOD with ESRD, cardiovascular disease, or heart failure after multivariable adjustment. Thus, low uUMOD levels may identify persons at risk of progressive kidney disease and mortality above and beyond established markers of kidney disease, namely eGFR and the albumin/creatinine ratio. Future studies need to confirm these results and evaluate whether uUMOD is a marker of tubular health and/or whether it plays a causal role in preserving kidney function.

[Indexed for MEDLINE]
Free PMC Article

Publication type, MeSH terms, Substances, Grant support

Publication type

MeSH terms


Grant support

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center